Differential κ-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 2, 1999, Pages 863-870

  Ignatowski, Tracey A ^a,b   Bidlack, Jean M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOTIN; CD4 ANTIGEN; CD8 ANTIGEN; FLUORESCEIN; FLUORESCEIN ISOTHIOCYANATE; KAPPA OPIATE RECEPTOR; PHYCOERYTHRIN; THIOGLYCOLIC ACID;

ANIMAL CELL; ARTICLE; CELL MATURATION; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; THYMOCYTE;

ANIMALS; B-LYMPHOCYTES; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; PHYCOERYTHRIN; RECEPTORS, OPIOID, KAPPA; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

EID: 0032788681     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Alicea C, Belkowski S, Eisenstein TR, Adler MW and Rogers TJ (1996) Inhibition of primary murine macrophage cytokine production in vitro following treatment with the κ-opioid agonist U50,488H. J Neuroimmunol 64:83-90.
2. Baker LA and Campbell PA (1980) Thioglycollate-medium decreases resistance to bacterial infection in mice. Infect Immunity 27:455-460.
3. Beavis AJ and Pennhne KJ (1994) Simultaneous measurement of five-cell surface antigens by five-colour immunofluorescence. Cytometry 15:371-376.
4. Belkowski SM, Zhu J, Liu-Chen L-Y, Eisenstein TK, Adler MW and Rogers TJ (1995) Detection of kappa-opioid receptor mRNA in immature T-cells. Adv Exp Med Biol 373:11-16.
5. Bidlack JM, Lawrence DMP and Ignatowski TA (1996) Kappa opioid receptors on immune cells as studied by fluorescent ligands. Adv Exp Med Biol 402:13-22.
6. Bidlack JM, Saripalli LD and Lawrence DMP (1992) κ-Opioid binding sites on a marine lymphama cell line. Eur J Pharmacol 227:257-265.
7. Chao CC, Gekker G, Hu S, Sheng WS, Bu D-F, Archer S, Bidlack JM and Peterson PK (1996) Kappa opioid receptors in human microglia downregulate human immunodeficiency virus-1 expression. Proc Natl Acad Sci USA 93:8051-8056.
8. Chuang LF, Chuang TK, Killam KF Jr, Chuang AJ, Kung H, Yu L and Chuang RY (1994) Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun 202:1291-1299.
9. Doe WF and Henson PM (1978) Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells. J Exp Med 148:544-556.
10. Doe WF, Yang ST, Morrison DC, Betz SJ and Henson PM (1978) Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signal delivered by lipid A and by a protein rich fraction of lipopolysaccharides. J Exp Med 148:557-568.
11. Eichner RD and Smeaton TC (1983) Agar accumulates in rat peritoneal macrophages elicited with thioglycollate broth. Scand J Immunol 18:259-263.
12. Fisker S, Kudahl K and Sonne O (1992) In vivo inflammatory stimulation induces a transient change in the binding of thrombin to rat peritoneal macrophages. Exp Cell Res 201:145-153.
13. Foster JS and Moore RN (1987) Dynorphin and related opioid peptides enhance tumoricidal activity mediated by m urine peritoneal macrophages. J Leukocyte Biol 42:171-174.
14. Gaveriaux C, Peluso J, Simonin F, LaForet J and Kieffer B (1995) Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett 369:272-276.
15. Hendrzak JA, Wallace PK and Morahan PS (1994) Optimizing the detection of cell surface antigens on elicited or activated mouse peritoneal macrophages. Cytometry 17:349-356.
16. Ho M-K and Springer TA (1983) Tissue distribution, structural characterization, and biosynthesis of Mac-3, a macrophage surface glycoprotein exhibiting molecular weight heterogeneity. J Biol Chem 258:636-642.
17. Ichinose M, Asai M and Sawada M (1995) Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages. J Neuroimmunol 60:37-43.
18. Ignatowski TA and Bidlack JM (1998) Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry. J Pharmacol Exp Ther 284:298-306.
19. Ignatowski TA and Spengler RN (1995) Regulation of macrophage-derived tumor necrosis factor (TNF) production by modification of adrenergic receptor sensitivity. J Neuroimmunol 61:61-70.
20. Karnovsky ML and Lazdins JK (1978) Biochemical criteria for activated macrophages. J Immunol 121:809-813.
21. Kowalski J (1998) Immunomodulatory action of class mu-, delta-, and kappa-opioid receptor agonists in mice. Neuropeptides 32:301-306.
22. Lawrence DMP and Bidlack JM (1992) Kappa opioid binding sites on the R1.1 murine lymphoma cell line: Sensitivity to cations and guanine nucleotides. J Neuroimmunol 41:223-230.
23. Lawrence DMP, El-Hamouly W, Archer S, Leary JF and Bidlack JM (1995a) Identification of K opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci USA 92:1062-1066.
24. Lawrence DMP, Hutchison I, Seyed-Mozaffari A, Archer S and Bidlack JM (1997) Fluorescent staining of kappa opioid receptors in the immune system using naltrexamine derivatives and phycoerythrin. J Immunol Methods 201:173-181.
25. Lawrence DMP, Joseph DB and Bidlack JM (1995b) Kappa opioid receptors expressed on three related cell lines: Differences in receptor-effector coupling. Biochem Pharmacol 49:81-89.
26. Melnicoff MJ, Horan PK and Morahan PS (1989) Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 118:178-191.
27. Morahan PS, Rozner MA and Jessee EJ (1982) Effect of elicitation on peritoneal macrophage subpopulations: Size distributions, ectoenzyme phenotypes and antitumor activity. Int J Cancer 30:787-794.
28. North RJ (1978) The concept of the activated macrophage. J Immunol 121:806-809.
29. Plasman N and Vray B (1994) Immunophenotyping of murine peritoneal macrophages and lymphocytes by flow cytometry. J Immunol Methods 174:123-131.
30. Portoghese PS, Lipkowski AW and Takemori AE (1987) Binaltorphimine and norbinaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 40: 1287-1292.
31. Prete P, Levin ER and Pedram A (1986) The in vitro effects of endogenous opioids on natural killer cells, antigen-specific cytolytic T-cells, and T-cell subsets. Exp Neurol 92:349-359.
32. Radulovic J, Miljevic C, Djergovic D, Vujic V, Antic J, von Horsten S and Jankovic BD (1995) Opioid-receptor mediated suppression of humoral immune response in vivo and in vitro: Involvement of κ opioid receptors. J Neuroimmunol 57:55-62.
33. Remick DG, Stricter RM, Lynch JP, Nguyen ME and Kunkel SL (1989) In vivo dynamics of murine tumor necrosis factor-α gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest 60:766-771.
34. Schafer M, Carter L and Stein C (1994) Interleukin 1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91:4219-4223.
35. Sedqi M, Roy S, Ramakrishnan S, Elde R and Loh HH (1995) Complementary DNA cloning of a μ-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun 209:563-574.
36. Sibinga NES and Goldstein A (1988) Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 8:219-249.
37. Smith EM and Blalock JE (1981) Human lymphocyte production of corticotropin and endorphin-like substances: Association with leukocyte interferon. Proc Natl Acad Sci USA 78:7530-7534.
38. Taub DD, Eisenstein TK, Geller EB, Adler MW and Rogers TJ (1991) Immunomodulatory activity of μ- and κ-selective opioid agonists. Proc Natl Acad Sci USA 88:360-364.
39. Wijffels JFAM, Hendrickx RJBM, Steenbergen JJE, Eestermans IL and Beelen RHJ (1992) Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages. Res Immunol 143:401-409.
40. Wollenberg GK, DeForge LE, Bolgos G and Remick DG (1993) Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture. Am J Pathol 143:1121-1130.